Sign in
4

Changes in Ownership

BIODESIX INC Filed Acc 0001140361-23-006076

President & CEO sold 16,278 shares at $1.80 ($29,286)

  • President & CEO acquired 44,777 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hutton Scott · President & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-02-08 Exercise or conversion : show line 1 in the form +44,777 216,004 D
2023-02-09 Sale : show line 2 in the form −16,278 $1.80 $29,286 199,726 D
Open-market sales · 16,278 sh · avg $1.80 · $29,286

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2023-02-08 Grant or award : show line 3 in the form Restricted Stock Units +751,042 751,042 D
2023-02-08 Exercise or conversion : show line 4 in the form Restricted Stock Units −12,212 146,544 D
2023-02-08 Exercise or conversion : show line 5 in the form Restricted Stock Units −32,565 65,131 D
Loading xslF345X03/form4.xml…